Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Naoto Katakami

Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross-sectional study.

scientific article published on 8 February 2017

Clinical utility of carotid ultrasonography: Application for the management of patients with diabetes

scientific article published on 15 April 2019

Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1-year period

scientific article published on 18 September 2019

Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patients

scientific article published on 07 June 2018

Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE).

scientific article

Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial

scientific article published on 12 January 2018

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes

scientific article published on 18 November 2020

Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes

scientific article published on 11 June 2020

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized-treatment

scientific article published on 19 November 2020

Preoperative fundus examination in patients with diabetes scheduled for surgery

scientific article published on 15 December 2020

Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan-A Protocol.

scientific article published on 19 December 2017

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

scientific article published on September 2017

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study

scientific article published on 09 July 2020